check_circleStudy Completed

Diagnostic Imaging, Heart Defects, Congenital

Dose finding study with SH U 454 as an echocardiographic contrast agent for clarification of congenital malformations involving the right heart in patients from 0 - 18 years

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

1 - 18 Years
  • -

  • -

Trial summary

Enrollment Goal
49
Trial Dates
August 1986 - December 1988
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Echovist (α-D-Galactose, BAY86-4872)
Accepts Healthy Volunteer
N/A

Trial design

Open, uncontrolled dose finding study with SH U 454 as an echocardiographic contrast agent for clarification of congenital malformations involving the right heart in patients from 0 - 18 years
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A